OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $852,000 | -23.6% | 172,100 | +7.6% | 0.00% | -100.0% |
| Q4 2021 | $1,115,000 | -22.2% | 160,000 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $1,433,000 | -28.4% | 143,300 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $2,001,000 | -12.0% | 141,100 | +1.8% | 0.00% | -50.0% |
| Q1 2021 | $2,274,000 | -19.9% | 138,600 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,838,000 | +2066.4% | 137,100 | +621.6% | 0.00% | – |
| Q3 2016 | $131,000 | +39.4% | 19,000 | 0.0% | 0.00% | – |
| Q2 2016 | $94,000 | -39.7% | 19,000 | +13.1% | 0.00% | – |
| Q1 2016 | $156,000 | +27.9% | 16,800 | +29.2% | 0.00% | – |
| Q4 2015 | $122,000 | -33.3% | 13,000 | 0.0% | 0.00% | – |
| Q3 2015 | $183,000 | -19.4% | 13,000 | +20.4% | 0.00% | -100.0% |
| Q2 2015 | $227,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |